Home Seattle Genetics: 3 Reasons Why I Like This Midcap Biotech
 

Keywords :   


Seattle Genetics: 3 Reasons Why I Like This Midcap Biotech

2015-09-30 20:28:30| Biotech - Topix.net

Adcetris is in the midst of three Phase 3 and four Phase 2 trials to test its viability in treating other cancers and lymphoma. In the world of small- and mid-cap biotech companies it's often times a feast or famine proposition.

Tags: this reasons seattle genetics

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
03.07Lakamps research aims to use cattle genetics and microbiome information to make performance predictions
03.07Keep livestock safe during hurricane season with an emergency plan
03.07Making the most of forage resources
03.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Hurricane Beryl Graphics
02.07Hurricane Beryl Forecast Discussion Number 17
02.07Hurricane Beryl Forecast Advisory Number 17
02.07Ansell Completes Acquisition of Kimberly-Clarks PPE Business
More »